Cost Effectiveness of Early Treatment of Parkinson’s Disease in Mexico

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.1655
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness Analysis of Amfepramone (Diethylpropion) for the Obesity Treatment in Mexico

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Effectiveness of Mometasone Furoate Nasal Spray in the Treatment of Rhinosinusitis in Mexico

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Nd4 - Cost-Effectiveness Evaluation of the Intra-Duodenal Continuous Levodopa Infusion in Advanced and Severe Parkinson’s Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Laboratory Biomarkers of Early Diagnosis of Parkinson’s Disease

INTERNATIONAL NEUROLOGICAL JOURNAL
2016English

Cost-Effectiveness Analysis of the Treatment of Mild and Moderate Alzheimer’s Disease in Brazil

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2019English

The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2017English

Applying Telemedicine in Rehabilitation and Treatment of Parkinson’s Disease

Acta Healthmedica
2017English

Prs42 - Cost-Effectiveness of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical Benefits, Costs, and Cost-Effectiveness of Neonatal Intensive Care in Mexico

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy